Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
appeal, Arkin, bid, brain, cancelled, CEO, characterized, coinsurance, consecutive, delisted, delisting, dysregulated, EIGR, exaggerated, improbable, inflationary, influenza, insulin, letter, MBA, MD, minimum, nonconforming, outsourced, Panel, PhD, PHE, pose, prenylation, publicly, Recordati, regain, regained, resurgence, round, runway, split, sugar, symbol, Telemetry, undertaken, Vogenx, workforce
Removed:
BlackRock, boosted, disproportionate, distancing, emergence, EUA, expansion, farnesylation, Gilead, HCV, hepatotoxicity, host, immunological, Kayaku, managerial, managing, moderate, myalgia, Nippon, peptide, platform, port, pyrexia, replication, Replicor, ritonavir, sheet, social, supplier, topline, Trust, unmet, viral
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view